TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CERS

Cerus Corporation

Healthcare · Medical Devices

2.60$ +0.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Cerus Corporation (CERS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 205 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CERS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
116 103 85 83 97 98 144 152 162 163 176 175 164 166 215 215 213 221 221 223 219 237 222 216 215 218 209 199 206 198 189 185 190 201 207 213 215 222 223 205
108 94 76 74 88 90 134 141 150 147 135 136 126 128 178 179 177 183 181 186 178 187 173 165 165 170 162 151 151 144 138 135 141 152 162 169 167 174 175 157
13 23 11 20 17 14 15 14 22 29 29 24 24 35 34 35 29 37 58 59 78 49 38 32 29 36 28 21 17 12 21 12 22 20 19 16 16 20 28 18
81 72 54 51 60 61 106 112 119 118 100 96 85 86 133 136 135 134 132 123 120 129 109 107 104 102 95 85 79 66 72 71 76 80 81 78 79 83 80 56
7.4 6.9 5.6 7.9 10 12 10 11 10 8.8 14 13 15 17 18 18 16 21 22 29 25 25 26 27 28 34 25 22 25 36 23 24 24 30 26 31 30 30 29 31
12 13 13 12 14 14 13 13 13 14 16 17 21 19 22 18 19 23 24 31 29 27 29 28 28 29 37 41 43 40 40 36 37 38 48 55 53 56 61 66
3.2 3.0 2.8 2.7 2.3 2.1 2.0 2.2 3.1 8.1 16 15 15 15 15 15 14 14 13 25 13 25 12 11 11 11 11 – – – – – – – – – – – – –
1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3
0.8 0.7 0.7 0.6 0.6 0.5 0.5 0.4 0.4 0.3 0.3 0.2 0.2 0.1 0.1 0.0 – – – – – – – – – – – – – – – – – – – – – – – –
44 46 43 44 60 59 59 61 70 79 106 109 104 108 103 101 104 118 128 139 138 152 141 140 141 150 150 147 157 144 139 135 135 144 151 157 153 157 155 134
23 27 26 25 24 23 24 28 43 53 48 51 46 50 45 43 46 60 55 66 65 79 67 79 95 117 78 75 80 68 57 54 54 64 70 84 88 101 107 86
5.0 6.9 7.7 5.5 30 12 1.4 3.6 5.7 7.9 1.6 6.2 6.6 6.6 6.6 6.7 6.8 10 11 11 12 17 17 31 44 58 20 19 21 20 22 21 21 22 23 31 39 46 56 33
6.9 8.6 8.8 9.6 13 23 11 11 14 19 21 21 20 22 20 19 19 24 23 31 26 36 31 29 30 33 36 37 39 24 17 17 16 22 28 31 25 28 32 34
14 12 10 12 30 30 28 26 24 22 39 39 39 39 39 40 40 40 55 55 55 55 55 41 27 14 55 55 60 60 65 65 65 65 65 57 49 41 32 35
72 58 41 39 37 39 86 90 92 85 70 66 61 57 112 115 109 104 93 84 80 85 79 76 73 68 59 51 48 53 49 50 53 56 55 55 61 64 68 70
-647 -661 -679 -696 -710 -721 -735 -748 -763 -779 -798 -815 -833 -850 -867 -881 -896 -910 -927 -943 -955 -964 -977 -985 -993 -1,007 -1,023 -1,036 -1,043 -1,045 -1,054 -1,060 -1,063 -1,066 -1,073 -1,079 -1,079 -1,081 -1,083 -1,086
103 103 104 105 110 114 125 131 134 136 137 138 141 143 157 164 167 167 169 171 172 173 174 177 177 177 178 181 181 181 182 185 185 185 187 191 192 192 194 201

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?